Comparative study of the effect of the effect of carbadox, olaquindox and cyadox on aldosterone, sodium and potassium plasma levels in weaned pigs.
To study the effects of olaquindox and cyadox on aldosterone, sodium and potassium in the blood in comparison with the effects of carbadox, weaned pigs were fed these compounds in different doses. Pigs treated with 100 and 200 ppm carbadox showed a significant decline of aldosterone after five and three weeks, respectively, compared with control values. In the 200 ppm group treatment was interrupted at week 4. With olaquindox a continuous, significant decline was found from 50 ppm and above after five weeks, and from 25 ppm and above (but excluding the 100 ppm group), after six weeks. In the cyadox groups a significant decline was measured after six weeks in the 50, 200 and 400 ppm groups. Only the 200 ppm group had an earlier response at three and five weeks. A decrease of sodium to hyponatraemic levels in the carbadox groups was seen after three weeks in the 200, and after five weeks in the 100 ppm group. In the olaquindox groups only the 200 ppm dosage showed a consistent decrease to hyponatraemic levels from four weeks treatment. In the cyadox groups the 200 ppm dosage reached a hyponatraemic level after six weeks. An increase of potassium to hyperkalaemic levels occurred at 100 and 200 ppm carbadox dosage after four and three weeks, respectively, and at 200 ppm olaquindox dosage after four weeks. No hyperkalaemic levels were seen in the cyadox groups. It is concluded that the toxic effect of olaquindox, despite minor differences, is comparable with that of carbadox but that cyadox is less toxic.
Central Veterinary Institute, Lelystad, The Netherlands.
E J
EJ
van der Molen
A J
AJ
Baars
G J
GJ
de Graaf
L P
LP
Jager
D000450:Aldosterone / Q000097:blood; D000821:Animal Feed / Q000633:toxicity*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000633:toxicity*; D002218:Carbadox / Q000633:toxicity*; D005260:Female; D008297:Male; D011188:Potassium / Q000097:blood; D011810:Quinoxalines / Q000633:toxicity*; D012964:Sodium / Q000097:blood; D013552:Swine / Q000097:blood*
D000900:Anti-Bacterial Agents; D011810:Quinoxalines; D000450:Aldosterone; C020728:cyadox; D012964:Sodium; C013168:olaquindox; D002218:Carbadox; D011188:Potassium